SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injur…

Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong ...
Nasdaq

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac ...

DENVER, April 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients ...
Medscape

SCD Impairs T-Cell Function in Cancer

Sickle cell disease (SCD) altered CD8+ T-cell chromatin architecture, triggering ferroptosis and weakening antitumor immunity. Hydrogen sulfide (H2S) treatment restored chromatin interactions and ...

Gujarat Biotechnology University to host two-day conference to delve into rise in sudden cardiac deaths

CRC-2025 seeks to catalyse a national response to the growing crisis of Sudden Cardiac Deaths by convening a dynamic exchange among cardiologists, biotechnologists, AI specialists, and public health ...